In its complaint, the FTC alleged WCAS, through its portfolio company USAP, participated in an anticompetitive scheme to consolidate anesthesiology practices in Texas and increase prices to patients for profit.
Under a proposed consent order, WCAS will be required to limit its involvement with USAP and notify the FTC of specified future acquisitions and investments in anesthesia and other hospital-based physician practices.
USAP sought to appeal the lawsuit in August 2024. Shortly thereafter, The 5th U.S. Circuit Court of Appeals in New Orleans ruled that it would not take up USAP’s appeal to block the antitrust lawsuit.
Becker’s has reached out to WCAS for comment and will update this article if more information becomes available.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
